Search

Search Constraints

You searched for: Author/Creator Kestemont, Philippe

Search Results

1. 9. Efficacy and safety of a ready-to-use liquid formulation of abobotulinumtoxinA lyophilisate in moderate to severe glabellar lines: results of a phase 2 randomized, placebo-controlled clinical trial. (January 2015)

3. A hyaluronic acid‐based filler reduces lipolysis in human mature adipocytes and maintains adherence and lipid accumulation of long‐term differentiated human preadipocytes. (4th November 2020)

5. Comparative clinical study for the efficacy and safety of two different hyaluronic acid‐based fillers with Tri‐Hyal versus Vycross technology: A long‐term prospective randomized clinical trial. (19th July 2022)

6. Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines. (19th March 2021)

7. Efficacy, Safety, and Subject Satisfaction After AbobotulinumtoxinA Treatment of Upper Facial Lines. Issue 12 (December 2018)

9. IncobotulinumtoxinA Is an Effective and Well-Tolerated Treatment for Upper Facial Lines: Results From an Open-Label Extension Period of a Phase III Study. (December 2017)